Alterations in DNA damage repair genes in primary liver cancer.

CONCLUSIONS: The landscape of DDR mutations and their association with genetic and clinicopathological features demonstrated that PLC patients with altered DDR genes may be rational candidates for precision oncology treatment.
PMID: 31068370 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - May 7, 2019 Category: Cancer & Oncology Authors: Lin J, Shi J, Guo H, Yang X, Jiang Y, Long J, Bai Y, Wang D, Yang X, Wan X, Zhang L, Pan J, Hu K, Guan M, Huo L, Sang X, Wang K, Zhao H Tags: Clin Cancer Res Source Type: research